<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=CRISPLD2</id>
	<title>CRISPLD2 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=CRISPLD2"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=CRISPLD2&amp;action=history"/>
	<updated>2026-06-15T16:18:07Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=CRISPLD2&amp;diff=6264&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Cysteine-rich secretory protein LCCL domain-containing 2 precursor (Cysteine-rich secretory protein 11) (CRISP-11) (LCCL domain-containing cysteine-rich secretory...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=CRISPLD2&amp;diff=6264&amp;oldid=prev"/>
		<updated>2021-05-12T15:20:10Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Cysteine-rich secretory protein LCCL domain-containing 2 precursor (Cysteine-rich secretory protein 11) (CRISP-11) (LCCL domain-containing cysteine-rich secretory...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Cysteine-rich secretory protein LCCL domain-containing 2 precursor (Cysteine-rich secretory protein 11) (CRISP-11) (LCCL domain-containing cysteine-rich secretory protein 2) [CRISP11] [LCRISP2] [UNQ2914/PRO1156/PRO9783]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=A large-scale CRISPR screen and identification of essential genes in cellular senescence bypass.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31219803&lt;br /&gt;
|abstract=Cellular senescence is an important mechanism of autonomous tumor suppression, while its consequence such as the senescence-associated secretory phenotype (SASP) may drive tumorigenesis and age-related diseases. Therefore, controlling the cell fate optimally when encountering senescence stress is helpful for anti-cancer or anti-aging treatments. To identify genes essential for senescence establishment or maintenance, we carried out a CRISPR-based screen with a deliberately designed single-guide RNA (sgRNA) library. The library comprised of about 12,000 kinds of sgRNAs targeting 1378 senescence-associated genes selected by integrating the information of literature mining, protein-protein interaction network, and differential gene expression. We successfully detected a dozen gene deficiencies potentially causing senescence bypass, and their phenotypes were further validated with a high true positive rate. RNA-seq analysis showed distinct transcriptome patterns of these bypass cells. Interestingly, in the bypass cells, the expression of SASP genes was maintained or elevated with [[CHEK2]], [[HAS1]], or [[MDK]] deficiency; but neutralized with [[MTOR]], [[CRISPLD2]], or [[MORF4L1]] deficiency. Pathways of some age-related neurodegenerative disorders were also downregulated with [[MTOR]], [[CRISPLD2]], or [[MORF4L1]] deficiency. The results demonstrated that disturbing these genes could lead to distinct cell fates as a consequence of senescence bypass, suggesting that they may play essential roles in cellular senescence.&lt;br /&gt;
|mesh-terms=* CRISPR-Associated Protein 9&lt;br /&gt;
* CRISPR-Cas Systems&lt;br /&gt;
* Cell Line&lt;br /&gt;
* Cellular Senescence&lt;br /&gt;
* Fibroblasts&lt;br /&gt;
* Gene Expression Regulation&lt;br /&gt;
* Humans&lt;br /&gt;
* Lentivirus&lt;br /&gt;
|keywords=* CRISPR&lt;br /&gt;
* SASP&lt;br /&gt;
* aging&lt;br /&gt;
* bypass&lt;br /&gt;
* cellular senescence&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628988&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>